Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 2.156 5-jähriger Impact-Faktor: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v11.i1-3.50
44 pages

New Prospectives of Prostate Cancer Gene Therapy: Molecular Targets and Animal Models

Chia-Ling Hsieh
Departments of Urology, University of Virginia School of Medicine, Charlottesville, VA 22908
Leland W. K. Chung
Departments of Urology and Cell Biology, University of Virginia School of Medicine, Charlottesville, VA 22908

ABSTRAKT

Prostate cancer is the most common cancer and the second leading cause of cancer-related death among North American men. The low cure rate for prostate cancer is associated with the fact that many patients have metastatic disease at the time of disease presentation. Currently available therapeutic modalities for prostate cancer, such as surgery, radiation, hormone therapy, and chemotherapy, have failed to cure patients because these therapies are not sufficiently tumor-specific, resulting in dose-limiting toxicity. Therefore, gene therapy may offer great promise in this regard. In this article, we summarize current advances in gene therapy technologies for the treatment of cancer in general, and future prospects for treatment of human prostate cancer metastasis. We specifically emphasize current studies for improvement, both in the efficiency and the specificity of viral and nonviral vectors, and restricted transgene expression in tumors, to achieve selective targeting with minimized host organ toxicity, based on the molecular understanding of potential regulatory differences between normal and tumor cells. Cell and animal models used to study prostate cancer growth, invasion, and metastasis, and their usefulness in preclinical evaluation of therapeutic vectors in the treatment of protate cancer skeletal metastasis are also discussed.


Articles with similar content:

Therapeutic Intervention with Breast Cancer Metastasis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 2
Dina Chelouche Lev, Janet E. Price
Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
Critical Reviews™ in Immunology, Vol.39, 2019, issue 3
Farwah Jameel, Muhammad Irfan, Rida Fatima Ahmed
Circulating Tumor Cells in Breast Cancer Patients
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Lily Valad, Carolyn Hall, Anthony Lucci
Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 5-6
Monica Cheng, Hristos Z. Kaimakliotis, Shaobo Zhang, Catherine R. Miller, Antonio Lopez-Beltran, Michael O. Koch, Yu Yang, Rodolfo Montironi, Liang Cheng
MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 2
Faezeh Ghasemi, Atefeh Amiri, Hamed Mirzaei, Aria Masoudifar, Reza Salarinia, Arad Mobasher Aghdam